InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

VVOS Insider Trading

Insider Ownership Percentage: 9.60%
Insider Buying (Last 12 Months): $30,420.00
Insider Selling (Last 12 Months): $0.00

Vivos Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Vivos Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vivos Therapeutics Share Price & Price History

Current Price: $4.40
Price Change: ▲ Price Increase of +0.17 (4.02%)
As of 11/28/2023 01:00 AM ET

This chart shows the closing price history over time for VVOS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Vivos Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/20/2023Ronald Kirk HuntsmanCEOBuy560$13.25$7,420.003,460View SEC Filing Icon  
6/16/2023Ronald Kirk HuntsmanCEOBuy600$13.50$8,100.002,900View SEC Filing Icon  
6/14/2023Ronald Kirk HuntsmanCEOBuy400$12.25$4,900.002,300View SEC Filing Icon  
12/23/2022Ronald Kirk HuntsmanCEOBuy800$12.50$10,000.001,900View SEC Filing Icon  
5/31/2022Ronald Kirk HuntsmanCEOBuy320$50.75$16,240.00940View SEC Filing Icon  
9/21/2021Ronald Kirk HuntsmanCEOBuy200$107.75$21,550.00View SEC Filing Icon  
8/17/2021Ronald Kirk HuntsmanCEOBuy200$75.00$15,000.00420View SEC Filing Icon  
5/25/2021Bradford K. AmmanCFOBuy40$132.25$5,290.0080View SEC Filing Icon  
12/23/2020Ronald Kirk HuntsmanCEOBuy40$181.75$7,270.00View SEC Filing Icon  
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Vivos Therapeutics (NASDAQ:VVOS)

15.68% of Vivos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VVOS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vivos Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2023Two Sigma Investments LP91,013$31K0.0%N/A0.364%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC88,900$30K0.0%+455.6%0.355%Search for SEC Filing on Google Icon
4/24/2023Strategic Wealth Investment Group LLC3,219,705$1.10M0.2%N/A12.874%Search for SEC Filing on Google Icon
4/20/2023Strategic Wealth Investment Group LLC232,737$1.10M0.2%N/A0.931%Search for SEC Filing on Google Icon
4/18/2023Godsey & Gibb Inc.92,999$32K0.0%N/A0.372%Search for SEC Filing on Google Icon
2/10/2023Bard Associates Inc.201,704$81K0.0%-6.9%0.806%Search for SEC Filing on Google Icon
11/16/2022SeaCrest Wealth Management LLC40,000$26K0.0%N/A0.174%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.731,378$0.48M0.0%+5.2%3.178%Search for SEC Filing on Google Icon
11/9/2022Boston Partners78,454$51K0.0%-36.8%0.341%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.365,901$0.24M0.0%-11.1%1.590%Search for SEC Filing on Google Icon
10/24/2022Perkins Capital Management Inc.56,500$37K0.0%-65.5%0.246%Search for SEC Filing on Google Icon
7/29/2022Perkins Capital Management Inc.163,800$0.21M0.2%+9.2%0.712%Search for SEC Filing on Google Icon
7/29/2022Russell Investments Group Ltd.411,589$0.53M0.0%-3.1%1.789%Search for SEC Filing on Google Icon
5/16/2022State Street Corp45,650$0.12M0.0%+150.4%0.198%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC10,900$29K0.0%N/A0.047%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.695,051$1.86M0.0%+4.8%3.021%Search for SEC Filing on Google Icon
5/10/2022Boston Partners137,354$0.37M0.0%+27.2%0.597%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.424,801$1.14M0.0%+39.2%1.846%Search for SEC Filing on Google Icon
5/2/2022National Asset Management Inc.98,574$0.27M0.0%+24.4%0.428%Search for SEC Filing on Google Icon
4/20/2022Perkins Capital Management Inc.150,050$0.40M0.3%+10.3%0.652%Search for SEC Filing on Google Icon
4/12/2022Griffin Asset Management Inc.70,200$0.19M0.0%+63.3%0.305%Search for SEC Filing on Google Icon
2/10/2022Perkins Capital Management Inc.136,050$0.31M0.2%-7.1%0.591%Search for SEC Filing on Google Icon
2/4/2022Boston Partners108,015$0.24M0.0%+131.5%0.469%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.19,200$43K0.0%+60.0%0.083%Search for SEC Filing on Google Icon
1/28/2022Griffin Asset Management Inc.43,000$97K0.0%-13.1%0.187%Search for SEC Filing on Google Icon
1/28/2022National Asset Management Inc.79,270$0.18M0.0%+55.5%0.344%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.305,096$0.68M0.0%+554.0%1.326%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC34,443$0.14M0.0%N/A0.151%Search for SEC Filing on Google Icon
11/16/2021National Asset Management Inc.50,987$0.21M0.0%+46.9%0.224%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP157,324$0.64M0.0%N/A0.690%Search for SEC Filing on Google Icon
11/12/2021WMS Partners LLC12,167$49K0.0%-27.0%0.053%Search for SEC Filing on Google Icon
11/12/2021Blueshift Asset Management LLC18,826$76K0.0%N/A0.083%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.48,905$0.20M0.0%+255.8%0.214%Search for SEC Filing on Google Icon
11/8/2021Avalon Investment & Advisory329,322$1.33M0.0%+73.6%1.444%Search for SEC Filing on Google Icon
11/8/2021Russell Investments Group Ltd.46,651$0.19M0.0%N/A0.205%Search for SEC Filing on Google Icon
11/5/2021Boston Partners46,651$0.19M0.0%N/A0.205%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.12,000$48K0.0%-68.0%0.053%Search for SEC Filing on Google Icon
10/25/2021Perkins Capital Management Inc.146,500$0.59M0.4%-9.8%0.642%Search for SEC Filing on Google Icon
8/17/2021Walleye Capital LLC150,000$0.74M0.0%N/A0.658%Search for SEC Filing on Google Icon
8/16/2021WMS Partners LLC16,667$0.15M0.0%N/A0.073%Search for SEC Filing on Google Icon
8/16/2021Archon Capital Management LLC215,000$1.06M0.1%N/A0.942%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC19,200$95K0.0%N/A0.084%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp11,483$57K0.0%N/A0.050%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC47,661$0.24M0.0%+285.0%0.209%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.383,891$1.90M0.0%N/A1.683%Search for SEC Filing on Google Icon
8/12/2021Bard Associates Inc.215,500$1.07M0.3%N/A0.945%Search for SEC Filing on Google Icon
8/11/2021Millrace Asset Group Inc.93,993$0.47M0.2%N/A0.412%Search for SEC Filing on Google Icon
8/10/2021National Asset Management Inc.34,718$0.17M0.0%+21.9%0.152%Search for SEC Filing on Google Icon
8/10/2021Cambridge Investment Research Advisors Inc.37,551$0.19M0.0%N/A0.165%Search for SEC Filing on Google Icon
7/30/2021Avalon Investment & Advisory189,739$0.94M0.0%+12.0%0.832%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC15,846$0.11M0.0%N/A0.069%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC78,898$0.52M0.0%-5.4%0.346%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC15,846$0.11M0.0%N/A0.069%Search for SEC Filing on Google Icon
5/14/2021Alpha Paradigm Partners LLC9,921$66K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/14/2021K.J. Harrison & Partners Inc45,419$0.30M0.0%-50.3%0.249%Search for SEC Filing on Google Icon
5/13/2021Avalon Investment & Advisory169,414$1.13M0.0%N/A0.930%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC12,380$82K0.0%N/A0.068%Search for SEC Filing on Google Icon
5/10/2021Royce & Associates LP348,000$2.31M0.0%+16.0%1.911%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.11,541$77K0.0%N/A0.063%Search for SEC Filing on Google Icon
5/4/2021Griffin Asset Management Inc.59,700$0.40M0.1%N/A0.328%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC32,237$0.19M0.0%N/A0.182%Search for SEC Filing on Google Icon
2/16/2021Walleye Capital LLC74,500$0.44M0.0%N/A0.422%Search for SEC Filing on Google Icon
2/9/2021Perkins Capital Management Inc.20,000$0.12M0.1%N/A0.113%Search for SEC Filing on Google Icon
2/8/2021Royce & Associates LP300,000$1.77M0.0%N/A1.698%Search for SEC Filing on Google Icon
2/8/2021K.J. Harrison & Partners Inc91,322$0.54M0.1%N/A0.517%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vivos Therapeutics logo
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.
Read More on Vivos Therapeutics

Today's Range

Now: $4.40
Low: $4.07
High: $4.43

50 Day Range

MA: $7.27
Low: $2.73
High: $108.00

52 Week Range

Now: $4.40
Low: $2.73
High: $74.05

Volume

6,073 shs

Average Volume

41,193 shs

Market Capitalization

$5.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.75

Who are the company insiders with the largest holdings of Vivos Therapeutics?

Vivos Therapeutics' top insider investors include:
  1. Ronald Kirk Huntsman (CEO)
Learn More about top insider investors at Vivos Therapeutics.

Who are the major institutional investors of Vivos Therapeutics?

Vivos Therapeutics' top institutional investors include:
  1. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Vivos Therapeutics stock.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.